Evidence map›Paper›PMID 40536958›Full record

ArticleScience (New York, N.Y.)2025

Mechanism of release factor-mediated peptidyl-tRNA hydrolysis on the ribosome.

Elena V Aleksandrova, Egor A Syroegin, Ritwika S Basu, Alexander A Vassilevski, Matthieu G Gagnon, Yury S Polikanov

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Translation factors that keep the ribosome Pro-active.Microbiology and molecular biology reviews : MMBR · 2026
    Review
  2. Article
  3. Article
  4. Quality control and signaling pathways at stalled ribosomes.Experimental & molecular medicine · 2026
    Review
  5. Molecular architecture and diversity of StopGo/2A translational recoding.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elena V Aleksandrova *Department of Biological Sciences, University of Illinois at Chicago, Chicago, IL, USA.ORCID 0000-0002-1808-5319
Egor A Syroegin *Department of Biological Sciences, University of Illinois at Chicago, Chicago, IL, USA.ORCID 0000-0003-2753-3950
Ritwika S Basu *Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.ORCID 0000-0001-6410-7905
Alexander A VassilevskiShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.ORCID 0000-0002-1359-0076
Matthieu G GagnonDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.ORCID 0000-0003-4516-604X
Yury S PolikanovDepartment of Biological Sciences, University of Illinois at Chicago, Chicago, IL, USA.ORCID 0000-0002-5064-0327

Funding

X-ray Scattering Technology CoreP30GM133893 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI Sean McSweeney · 2019 to 2026
$38.6M
User Training and OutreachP30GM124165 · NIGMS · CORNELL UNIVERSITY · PI MALCOLM S. CAPEL · 2018 to 2026
$34.2M
Pixel Array Detector for Macromolecular CrystallographyS10OD021527 · OD · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2016 to 2016
$2.0M
Structural Basis for the Allosteric Mechanisms Regulating Ribosome FunctionR01GM136936 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GAGNON, MATTHIEU · 2020 to 2024
$1.8M
Molecular mechanisms of action of ribosome-targeting antibiotics.R01GM132302 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI POLIKANOV, YURY · 2019 to 2022
$1.3M
Structural basis for ribosome function and inhibition in bacteria.R35GM151957 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI YURY POLIKANOV · 2024 to 2026
$1.2M
Structural bases for protein synthesis quality controlR35GM158272 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MATTHIEU GAGNON · 2025 to 2026
$817k
NIGMS NIH HHS P30 GM124165NIGMS NIH HHS P30 GM133893NIGMS NIH HHS R01 GM132302NIGMS NIH HHS R01 GM136936NIGMS NIH HHS R35 GM151957NIGMS NIH HHS R35 GM158272NIH HHS S10 OD021527
6 · The paper itself

Abstract

Translation termination is essential in all living organisms because it ensures that proteins have lengths strictly defined by their genes. This universal process is mediated by peptide release factors (RFs) that recognize stop codons and catalyze the hydrolysis of peptidyl transfer RNA (peptidyl-tRNA) on the ribosome, presumably by activating a water molecule. We report structures of the bacterial ribosome in complex with peptidyl-tRNA and RFs in the prepeptide release state. No hydrolytic water molecule was seen in the peptidyl transferase center. Instead, RFs induced rearrangements of the peptidyl-tRNA adenine 76 (A76) ribose pucker that orient the 2'-OH for the nucleophilic attack onto the neighboring carbonyl group. These findings suggest a catalytic mechanism of RF-mediated peptide release and provide a structural basis for the universal conservation of the catalytic domain in peptide RFs.

Indexed as

Peptide Chain Termination, TranslationalPeptide Termination FactorsRibosomesRNA, Transfer, Amino AcylThermus thermophilusCatalytic DomainCodon, TerminatorEscherichia coliEscherichia coli ProteinsGlutamineHydrolysisPeptidyl TransferasesCodon, TerminatorEscherichia coli ProteinsGlutaminePeptide Termination FactorsPeptidyl TransferasesRNA, Transfer, Amino AcyltRNA, peptidyl-

Identifiers

PMID40536958
PMCPMC12395469

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.